medical-device-presales-registration

Generates FDA and EU MDR registration pathway strategies with predicate analysis and final DOCX reports.

1|Updated Jul 13, 2026
One-click install
npx skills add https://github.com/HalseyYang/Skills-HY --skill medical-device-presales-registration-halseyyang
Or copy as Structured Prompt for Agent
Please help me install this Agent Skill.
Skill: medical-device-presales-registration
Source: https://github.com/HalseyYang/Skills-HY/tree/main/medical-device-presales-registration
Command: npx skills add https://github.com/HalseyYang/Skills-HY --skill medical-device-presales-registration-halseyyang

SYSTEM DOCUMENTATION & REQUIREMENTS

💡 This Skill includes references (resource) and assets (resource) components.

What problem does it solve? Evaluating a medical device's regulatory registration pathway for presales decisions requires verifying current FDA or EU MDR rules, classification, predicate devices, and clinical evidence requirements, which is slow and error-prone when done manually. ## Core Features & Use Cases - Target Market Gate: Confirms whether the project targets FDA, EU MDR, or multiple markets before starting any regulatory research. - Pathway & Predicate Strategy: Determines classification, 510(k)/De Novo/PMA or MDR conformity assessment routes, predicate/reference device selection, and testing, clinical, software, and usability evidence planning. - Three-Round Regulatory Audit: Internally audits evidence, regulatory logic, and final consistency, then delivers a short Executive Summary plus a complete Final DOCX built from a clean template. - Use Case: Upload a device specification and ask for a US registration assessment; the Skill verifies current FDA product codes and predicates, evaluates clinical evidence needs and Pre-Sub necessity, and returns a WeChat-ready summary plus a full strategy document. ## Quick Start Evaluate the registration pathway of my attached medical device for the US FDA market and give me a summary plus the full strategy document.

Frequently Asked Questions about medical-device-presales-registration

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I evaluate the FDA registration pathway for a medical device?

Provide the device documentation and specify the US market. The Skill verifies the product code and classification in FDA databases, selects primary and reference predicates from 510(k) or De Novo records, and designs the testing and clinical evidence plan.

How to determine if a medical device needs clinical trials for FDA or CE marking?

Clinical requirements are judged from regulations, special controls, predicate precedent, and the device's own claims and technical differences, not from device class alone. When uncertainty remains, the Skill recommends an FDA Pre-Sub or Notified Body consultation with specific questions.

Does this Skill support both FDA 510(k) and EU MDR assessments?

Yes, it covers FDA pathways including 510(k), De Novo, and PMA, as well as EU MDR classification under Annex VIII, conformity assessment, equivalence, and clinical evidence under Article 61. Multi-market projects such as FDA plus CE are also supported.

What output does the medical device registration evaluation produce?

A complete assessment delivers a short Executive Summary in the chat covering pathway, clinical requirements, key risks, and next steps, plus a full Final DOCX report built from a clean template. You can request summary-only or chat-only delivery instead.

Why does the Skill ask about target market before analyzing my device?

Classification, pathway, clinical evidence, and submission requirements differ between FDA, EU MDR, and other markets, so the target market is a mandatory precondition. Without it the Skill asks one question instead of guessing a market.

Can I use Chinese or European clinical data for an FDA submission?

The Skill evaluates whether OUS clinical data meets FDA acceptance conditions including GCP compliance, population transferability, and bridging needs. It does not assume US trials are mandatory or that foreign data is automatically sufficient.